160 related articles for article (PubMed ID: 8132753)
1. Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults.
Boulware SD; Tamborlane WV; Rennert NJ; Gesundheit N; Sherwin RS
J Clin Invest; 1994 Mar; 93(3):1131-9. PubMed ID: 8132753
[TBL] [Abstract][Full Text] [Related]
2. Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin.
Kerr D; Tamborlane WV; Rife F; Sherwin RS
J Clin Invest; 1993 Jan; 91(1):141-7. PubMed ID: 8423214
[TBL] [Abstract][Full Text] [Related]
3. Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback.
Chapman IM; Hartman ML; Pezzoli SS; Harrell FE; Hintz RL; Alberti KG; Thorner MO
J Clin Endocrinol Metab; 1997 Sep; 82(9):2996-3004. PubMed ID: 9284733
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human IGF-I on glucose and leucine kinetics in men.
Elahi D; McAloon-Dyke M; Fukagawa NK; Sclater AL; Wong GA; Shannon RP; Minaker KL; Miles JM; Rubenstein AH; Vandepol CJ
Am J Physiol; 1993 Dec; 265(6 Pt 1):E831-8. PubMed ID: 8279537
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
Laager R; Ninnis R; Keller U
J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
[TBL] [Abstract][Full Text] [Related]
6. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans.
Mauras N; Horber FF; Haymond MW
J Clin Endocrinol Metab; 1992 Nov; 75(5):1192-7. PubMed ID: 1430078
[TBL] [Abstract][Full Text] [Related]
7. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.
Hartman ML; Clayton PE; Johnson ML; Celniker A; Perlman AJ; Alberti KG; Thorner MO
J Clin Invest; 1993 Jun; 91(6):2453-62. PubMed ID: 8514857
[TBL] [Abstract][Full Text] [Related]
8. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.
Acerini CL; Harris DA; Matyka KA; Watts AP; Umpleby AM; Russell-Jones DL; Dunger DB
Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism.
Mauras N; Martinez V; Rini A; Guevara-Aguirre J
J Clin Endocrinol Metab; 2000 Sep; 85(9):3036-42. PubMed ID: 10999782
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E
J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
Mauras N; Doi SQ; Shapiro JR
J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human insulin-like growth factor-I abolishes changes in insulin requirements consequent upon growth hormone pulsatility in young adults with type I diabetes mellitus.
Crowne EC; Samra JS; Cheetham T; Watts A; Holly JM; Dunger DB
Metabolism; 1998 Jan; 47(1):31-8. PubMed ID: 9440474
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of rhIGF-1 in normal human subjects.
Rennert NJ; Boulware SD; Kerr D; Caprio S; Tamborlane WV; Sherwin RS
Adv Exp Med Biol; 1993; 343():311-8. PubMed ID: 8184741
[No Abstract] [Full Text] [Related]
14. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.
Saukkonen T; Shojaee-Moradie F; Williams RM; Amin R; Yuen KC; Watts A; Acerini CL; Umpleby AM; Dunger DB
Diabetes; 2006 Aug; 55(8):2365-70. PubMed ID: 16873702
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.
Saukkonen T; Amin R; Williams RM; Fox C; Yuen KC; White MA; Umpleby AM; Acerini CL; Dunger DB
J Clin Endocrinol Metab; 2004 Sep; 89(9):4634-41. PubMed ID: 15356074
[TBL] [Abstract][Full Text] [Related]
16. Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism.
Boulware SD; Tamborlane WV; Matthews LS; Sherwin RS
Am J Physiol; 1992 Jan; 262(1 Pt 1):E130-3. PubMed ID: 1733244
[TBL] [Abstract][Full Text] [Related]
17. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats.
Böni-Schnetzler M; Hauri C; Zapf J
Diabetologia; 1999 Feb; 42(2):160-6. PubMed ID: 10064095
[TBL] [Abstract][Full Text] [Related]
18. Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients.
Fouque D; Peng SC; Kopple JD
Kidney Int; 1995 Mar; 47(3):876-83. PubMed ID: 7752587
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect.
Mauras N; Beaufrere B
J Clin Endocrinol Metab; 1995 Mar; 80(3):869-74. PubMed ID: 7533772
[TBL] [Abstract][Full Text] [Related]
20. The effects of infusion of insulinlike growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs.
Douglas RG; Gluckman PD; Ball K; Breier B; Shaw JH
J Clin Invest; 1991 Aug; 88(2):614-22. PubMed ID: 1864971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]